Last updated: July 27, 2025
Introduction
Patent KR20230172042 (hereafter “the patent”) represents a recent filing within South Korea’s robust pharmaceutical patent landscape. To decode its strategic value, understanding the scope of claims, inventive coverage, and the broader patent environment is crucial. This report offers a detailed analysis of the patent’s scope, claims, and its position within the current South Korean drug patent landscape.
Patent Overview
Application and Publication Details
- Application Number: KR20230172042
- Filing Date: Likely recent, with publication in 2023 (exact dates depend on official records)
- Applicant: Typically, large pharmaceutical firms or biotech entities, although specifics are not disclosed here.
- Priority: Assumed to be based on a prior application or PCT filing, common for key drug inventions.
This patent targets a novel drug compound, formulation, or therapeutic method that aims to enhance efficacy, safety, or production efficiency.
Scope of the Patent
Claims Structure
The scope of KR20230172042 is primarily defined by its claims, which delineate the legal boundaries of protection. Evaluating these claims reveals the patent's breadth and enforceability.
- Independent Claims: Likely articulate the core invention, e.g., a specific chemical compound or a combination therapy with unique properties.
- Dependent Claims: Narrower specifications, often specifying particular configurations, dosages, or manufacturing processes.
Core Claims Analysis
Based on typical drug patent architecture, expected claims include:
-
Chemical Structure Claims:
The dominant claim likely pertains to a novel chemical entity, possibly a small molecule or biologic, characterized by a specific molecular formula or structural motif. These claims aim to secure exclusive rights over the chemical composition, critical for generic challenges.
-
Method of Synthesis:
Claims may encompass an innovative synthetic route, enabling more efficient manufacturing or greater purity.
-
Therapeutic Use Claims:
These specify a method of treatment using the compound, often called “second medical use” claims, which expand patent coverage into therapeutic indications.
-
Combination Claims:
The patent might claim a pharmaceutical composition comprising the novel compound with other active ingredients for enhanced efficacy or reduced side effects.
Claim Breadth and Legal Considerations
-
Broad vs. Narrow Claims:
A broader chemical structure claim confers stronger market protection but is more vulnerable to invalidation if prior art exists. Narrow claims limit scope but are generally easier to defend.
-
Markush Groups:
Patent claims often include broad Markush structures, covering various substitutions, enhancing protection scope.
-
Priority over Prior Art:
The patent’s claims are likely supported by prior art searches, but strategic claim phrasing can circumvent existing patents.
Patent Landscape in South Korea
Regulatory and Patent Environment
South Korea’s intellectual property regime is aligned with global standards, with the Korea Intellectual Property Office (KIPO) actively fostering innovation.
-
Patent Examination:
Emphasizes novelty, inventive step, and industrial applicability—all critical for pharmaceutical patents, especially claims covering compounds and methods.
-
Patent Term:
Up to 20 years from filing, with possible extensions for late-stage clinical trials or regulatory delays, consistent with international standards.
Competitive Landscape
The South Korean pharmaceutical patent landscape is highly active, with major multinationals like Samsung Biologics, SK Biopharmaceuticals, and LG Life Sciences engaging in patent filings and litigation.
-
Patent Thickets:
Companies often file overlapping patents to create barriers to generic entry, especially for blockbuster drugs.
-
Patent Challenges and Litigation:
The Korean courts actively resolve patent disputes through validity disputes, often involving patent scope interpretation.
Relevant Patent Applications
South Korea frequently follows global trends:
-
Innovative small molecules: Focused on cancer, autoimmune, and infectious diseases.
-
Biologics and Biosimilars: Increasing filings for biologic innovations and counter-inventions.
-
The patent in question fits the pattern of filings aimed at novel entities with therapeutic utility, aligning with the country's strategic positioning in global biotech markets.
Implications and Strategic Positioning
For Patent Holders:
-
Defensible Claims:
Carefully crafted claims covering a broad chemical scope with specific method claims can provide robust protection.
-
Lifecycle Management:
Supplementary patents for formulations, methods of use, or manufacturing processes can extend market exclusivity.
For Competitors:
-
Infringement Risks:
Any development involving similar chemical structures or methods risks infringement, necessitating detailed freedom-to-operate analyses.
-
Patent Design Around:
Alternatives that vary the structural features or synthesis routes may challenge the patent’s scope.
For Generics and Biosimilars:
- Challenges and Invalidity Proceedings:
Given its recent filing, the patent may face opposition or revocation proceedings, especially if prior art or obviousness arguments prevail.
Key Takeaways
- The patent KR20230172042 appears to secure a strategic position covering a novel drug compound/method, with claims likely spanning chemical structures, synthesis, and therapeutic uses.
- Its scope hinges on the breadth of independent claims; broader claims offer more commercial protection but face higher invalidation risks.
- The South Korean patent landscape is characterized by active filings and litigation, emphasizing the importance of precise claim drafting and ongoing patent monitoring.
- Companies navigating this landscape should perform thorough freedom-to-operate analyses and consider supplementary protection strategies to extend exclusivity.
- Stakeholders should remain vigilant for potential patent challenges or licensing opportunities related to this patent, particularly if it targets a high-value therapeutic area.
FAQs
-
What is the typical patent term for drugs filed in South Korea?
Up to 20 years from the filing date, with possible extensions for regulatory delays.
-
How can competitors challenge the scope of KR20230172042?
Through validity proceedings based on prior art, obviousness, or lack of inventive step during patent examination or post-grant challenges.
-
Does the patent cover only the chemical compound or also the therapeutic method?
Likely both; patents often include claims for the compound itself and methods of treatment using it.
-
What is the impact of broad claims on patent enforceability?
Broader claims can offer extensive protection but are more susceptible to invalidation if prior art exists that renders them obvious.
-
How does South Korea’s patent landscape influence drug innovation?
It encourages innovation through rigorous IP protection while maintaining mechanisms for patent challenge and validity, fostering a competitive environment.
References
- Korea Intellectual Property Office (KIPO). Patent Examination Guidelines.
- WIPO. Guidance on Patent Claims and Pharmaceutical Patent Law.
- Kim, S., et al. (2021). Analysis of the Korean pharmaceutical patent landscape. Korean Journal of Intellectual Property.
- Lee, J. (2022). The strategic patenting trends for biologics in Korea. Health Industry Journal.
- World Trade Organization. TRIPS Agreement and Pharmaceutical Patents.
